Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus
EPIRDEM
1 other identifier
interventional
50
1 country
1
Brief Summary
Hypothesis: Chronic intake of pistachios improves glucose metabolism and insulin resistance status thus contributing to decrease the risk of type 2 diabetes mellitus and its associated abnormalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Sep 2011
Longer than P75 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 20, 2011
CompletedFirst Posted
Study publicly available on registry
September 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedFebruary 11, 2019
February 1, 2019
5 years
September 20, 2011
February 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes from baseline in circulating levels of glucose and insulin according to the intervention arm
Measurement of circulating glucose and insulin levels and cellular glucose uptake
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
Secondary Outcomes (8)
Changes from baseline in inflammatory, oxidative and metabolic risk markers related to glucose/insulin metabolism according to the intervention arm
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
Changes from baseline in haemostatic parameters according to the intervention arm
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
Changes from baseline in HL and LDL size according to the intervention arm
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
Changes in advanced glycation end products according to the intervention arm
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
Changes from baseline in gene expression in the peripheral cells according to the intervention arm
Participants will be followed for 9 months. Measurements will be done before and after 4 months of the first and second intervention arm
- +3 more secondary outcomes
Study Arms (2)
Control diet
ACTIVE COMPARATORLow-fat normocaloric diet (30% fat, 55% carbohydrates, 15% proteins)
Pistachio diet
EXPERIMENTALDiet supplemented with 2 ounces of pistachio (35% fat, 50% carbohydrates adn 15% protein)
Interventions
Participants are randomised crossover clinical trial of 4-months trials separated by a 2-week washout period. Total duration of intervention and follow-up is nine months.
Participants are randomised crossover clinical trial of 4-months trials separated by a 2-week washout period. Total duration of intervention and follow-up is nine months.
Eligibility Criteria
You may qualify if:
- BMI less than 35 kg/m2.
- Fasting plasma glucose levels between 100 and 125 mg/dl or
- Oral glucose tolerance test of 140 to 199 mg/dl.
You may not qualify if:
- Diabetes mellitus.
- Alcohol, tobacco, or drug abuse.
- Significant liver, kidney, thyroid, or other endocrine diseases.
- Frequent consumption of nuts or known history of allergy to them.
- Use of plant sterol, oral antidiabetic drugs, supplemental use of phyllium, fish oil supplements and multivitamins, vitamin E or other antioxidant supplements.
- Bad dentures, implying difficulty to chew pistachios.
- Being pregnant or wishing to become a pregnant 6 months before or during the study, lactating 6wk before or during the study.
- Following vegetarian or weight loss diets.
- Other medical or social conditions that difficult the compliance to the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Human Nutrition Unit, Faculty of Medicine, Rovira i Virgili University
Reus, Tarragona, 43201, Spain
Related Publications (5)
Hernandez-Alonso P, Salas-Salvado J, Baldrich-Mora M, Mallol R, Correig X, Bullo M. Effect of pistachio consumption on plasma lipoprotein subclasses in pre-diabetic subjects. Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):396-402. doi: 10.1016/j.numecd.2015.01.013. Epub 2015 Feb 7.
PMID: 25791863BACKGROUNDHernandez-Alonso P, Salas-Salvado J, Baldrich-Mora M, Juanola-Falgarona M, Bullo M. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. Diabetes Care. 2014 Nov;37(11):3098-105. doi: 10.2337/dc14-1431. Epub 2014 Aug 14.
PMID: 25125505RESULTHernandez-Alonso P, Canueto D, Giardina S, Salas-Salvado J, Canellas N, Correig X, Bullo M. Effect of pistachio consumption on the modulation of urinary gut microbiota-related metabolites in prediabetic subjects. J Nutr Biochem. 2017 Jul;45:48-53. doi: 10.1016/j.jnutbio.2017.04.002. Epub 2017 Apr 12.
PMID: 28432876RESULTHernandez-Alonso P, Giardina S, Salas-Salvado J, Arcelin P, Bullo M. Chronic pistachio intake modulates circulating microRNAs related to glucose metabolism and insulin resistance in prediabetic subjects. Eur J Nutr. 2017 Sep;56(6):2181-2191. doi: 10.1007/s00394-016-1262-5. Epub 2016 Jul 6.
PMID: 27383196RESULTCanudas S, Hernandez-Alonso P, Galie S, Muralidharan J, Morell-Azanza L, Zalba G, Garcia-Gavilan J, Marti A, Salas-Salvado J, Bullo M. Pistachio consumption modulates DNA oxidation and genes related to telomere maintenance: a crossover randomized clinical trial. Am J Clin Nutr. 2019 Jun 1;109(6):1738-1745. doi: 10.1093/ajcn/nqz048.
PMID: 31051499DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monica Bullo, Dra.
Institut Investigacio Sanitaria Pere Virgili
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigators
Study Record Dates
First Submitted
September 20, 2011
First Posted
September 28, 2011
Study Start
September 1, 2011
Primary Completion
September 1, 2016
Study Completion
September 1, 2017
Last Updated
February 11, 2019
Record last verified: 2019-02